CN Patent

CN109836415B — 作为alk抑制剂的脲类化合物

Assigned to Beijing Boyuan Precision Medical Technology Co ltd · Expires 2020-11-06 · 6y expired

What this patent protects

本发明的目的是提供一种作为ALK抑制剂的脲类化合物及其药物组合物、制备方法和用途。该化合物具有如下通式(I)所示的结构。

USPTO Abstract

本发明的目的是提供一种作为ALK抑制剂的脲类化合物及其药物组合物、制备方法和用途。该化合物具有如下通式(I)所示的结构。

Drugs covered by this patent

Patent Metadata

Patent number
CN109836415B
Jurisdiction
CN
Classification
—
Expires
2020-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Boyuan Precision Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.